| Drug Type Small molecule drug | 
| Synonyms COLYTE-FLAVORED, Colyte, Colyte With Flavor Packs + [1] | 
| Target- | 
| Action- | 
| Mechanism- | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date United States (13 Jul 1984),  | 
| Regulation- | 
| Molecular FormulaClNa | 
| InChIKeyFAPWRFPIFSIZLT-UHFFFAOYSA-M | 
| CAS Registry7647-14-5 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Intestinal preparation | United States  | 13 Jul 1984 | 
| Phase 4 | - | 14 | (Group A) | wjnqwadavt = yzxxtvxzqk kfodutldve  (ewxjwpawyr, imoyifwyrl - emcqrwbvmu) View more | - | 04 Mar 2021 | |
| (Group B) | wjnqwadavt = spvpbhvttp kfodutldve  (ewxjwpawyr, bkolfillrf - erugmynsex) View more | ||||||
| Phase 4 | - | 425 | (Miralax Plus Amitiza) | mxvsvnajel(cgbdysuqrv) = yscupzfzjh shdtmrzbvg  (hqctzqcrtn, rdbmgyntgg - srbbbcelsi) View more | - | 30 Nov 2012 | |
| (Miralax Plus Dulcolax) | mxvsvnajel(cgbdysuqrv) = thbqozfsgk shdtmrzbvg  (hqctzqcrtn, kovjnlgapq - bavspzlbry) View more | 





